Reported Earnings • Jul 22
Second quarter 2026 earnings released: EPS: ₫120 (vs ₫733 in 2Q 2025) Second quarter 2026 results: EPS: ₫120 (down from ₫733 in 2Q 2025). Revenue: ₫28.5b (up 2.5% from 2Q 2025). Net income: ₫445.2m (down 84% from 2Q 2025). Profit margin: 1.6% (down from 9.8% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Board Change • Jun 23
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Phuong Dau was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • May 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 58% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 12% per year over the past 5 years. Market cap is less than US$10m (₫59.2b market cap, or US$2.25m). Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Large one-off items impacting financial results. Revenue is less than US$5m (₫114b revenue, or US$4.3m). Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₫18,700, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 10x in the Chemicals industry in Vietnam. Total loss to shareholders of 7.4% over the past three years. Reported Earnings • May 02
First quarter 2026 earnings released: EPS: ₫1,251 (vs ₫605 in 1Q 2025) First quarter 2026 results: EPS: ₫1,251 (up from ₫605 in 1Q 2025). Revenue: ₫27.1b (up 5.8% from 1Q 2025). Net income: ₫4.63b (up 223% from 1Q 2025). Profit margin: 17% (up from 5.6% in 1Q 2025). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Board Change • Apr 24
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). General Director & Vice Chairman Nhien Nguyen was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Apr 04
Dong Nai Paint Corporation, Annual General Meeting, Apr 22, 2026 Dong Nai Paint Corporation, Annual General Meeting, Apr 22, 2026, at 08:30 SE Asia Standard Time. Location: central park hotel no.128/6, tam hiep ward, dong nai province, Vietnam Board Change • Feb 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). General Director & Vice Chairman Nhien Nguyen was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Jan 23
Full year 2025 earnings released: EPS: ₫2,158 (vs ₫2,366 in FY 2024) Full year 2025 results: EPS: ₫2,158 (down from ₫2,366 in FY 2024). Revenue: ₫112.3b (down 6.1% from FY 2024). Net income: ₫6.69b (down 6.9% from FY 2024). Profit margin: 6.0% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Jan 19
Now 21% overvalued Over the last 90 days, the stock has fallen 9.6% to ₫25,300. The fair value is estimated to be ₫20,845, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.5% over the last 3 years. Earnings per share has declined by 13%. Board Change • Dec 30
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). General Director & Vice Chairman Nhien Nguyen was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Nov 20
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). General Director & Vice Chairman Nhien Nguyen was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Oct 17
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). General Director & Vice Chairman Nhien Nguyen was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Declared Dividend • Sep 05
First half dividend of ₫1,300 announced Shareholders will receive a dividend of ₫1,300. Ex-date: 12th September 2025 Payment date: 29th September 2025 Dividend yield will be 6.3%, which is higher than the industry average of 5.2%. Sustainability & Growth The dividend has remained flat since 4 years ago. However, payments have been volatile during that time. New Risk • Aug 12
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 0% Dividend per share is over 9x cash flows per share. Dividend yield: 5.5% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Dividend is not well covered by earnings and cash flows. Payout ratio: 0% Dividend per share is over 9x cash flows per share. Earnings have declined by 0.02% per year over the past 5 years. Market cap is less than US$10m (₫82.0b market cap, or US$3.12m). Minor Risks Profit margins are more than 30% lower than last year (7.0% net profit margin). Revenue is less than US$5m (₫117b revenue, or US$4.5m). Valuation Update With 7 Day Price Move • May 21
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₫21,200, the stock trades at a trailing P/E ratio of 8.4x. Average trailing P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 2.1% over the past three years. Declared Dividend • Feb 13
Final dividend of ₫500 announced Dividend of ₫500 is the same as last year. Ex-date: 3rd March 2025 Payment date: 20th March 2025 Dividend yield will be 5.4%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (23% earnings payout ratio) but not covered by cash flows (131% cash payout ratio). The dividend has remained flat since 4 years ago. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Jan 27
Full year 2024 earnings released: EPS: ₫2,366 (vs ₫4,342 in FY 2023) Full year 2024 results: EPS: ₫2,366 (down from ₫4,342 in FY 2023). Revenue: ₫119.6b (up 8.2% from FY 2023). Net income: ₫8.85b (down 46% from FY 2023). Profit margin: 7.4% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₫34,900, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 14x in the Chemicals industry in Vietnam. Total returns to shareholders of 103% over the past three years. Buy Or Sell Opportunity • Dec 19
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 1.7% to ₫29,000. The fair value is estimated to be ₫38,261, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last year. Earnings per share has declined by 54%. Buy Or Sell Opportunity • Oct 30
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.7% to ₫28,900. The fair value is estimated to be ₫38,010, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last year. Earnings per share has declined by 54%. New Risk • Oct 25
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 12% over the past year. Market cap is less than US$10m (₫97.2b market cap, or US$3.79m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (8.1% net profit margin). Revenue is less than US$5m (₫115b revenue, or US$4.5m). Buy Or Sell Opportunity • Sep 10
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 2.7% to ₫29,100. The fair value is estimated to be ₫38,144, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.1% over the last 3 years. Earnings per share has grown by 14%. Declared Dividend • Aug 24
Dividend of ₫1,000 announced Shareholders will receive a dividend of ₫1,000. Ex-date: 6th September 2024 Payment date: 20th September 2024 Dividend yield will be 5.5%, which is about the same as the industry average. Sustainability & Growth The dividend has increased by an average of 29% per year over the past 3 years and payments have been stable during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Buy Or Sell Opportunity • Aug 02
Now 22% undervalued Over the last 90 days, the stock has risen 3.9% to ₫29,500. The fair value is estimated to be ₫37,817, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.1% over the last 3 years. Earnings per share has grown by 14%. New Risk • May 12
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Market cap is less than US$10m (₫88.7b market cap, or US$3.46m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (8.1% net profit margin). Revenue is less than US$5m (₫115b revenue, or US$4.5m). Upcoming Dividend • Mar 04
Upcoming dividend of ₫500 per share Eligible shareholders must have bought the stock before 11 March 2024. Payment date: 27 March 2024. Payout ratio is a comfortable 55% but the company is not cash flow positive. Trailing yield: 5.8%. Lower than top quartile of Vietnamese dividend payers (8.7%). Higher than average of industry peers (4.5%). Declared Dividend • Feb 23
Dividend of ₫500 announced Shareholders will receive a dividend of ₫500. Ex-date: 11th March 2024 Payment date: 27th March 2024 Dividend yield will be 11%, which is higher than the industry average of 5.2%. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.3% per year over the past 3 years and payments have been stable during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₫28,300, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 124% over the past three years. New Risk • Oct 27
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.1% Last year net profit margin: 16% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Market cap is less than US$10m (₫94.1b market cap, or US$3.83m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (8.1% net profit margin). Revenue is less than US$5m (₫115b revenue, or US$4.7m). Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: ₫524 (vs ₫2,129 in 3Q 2022) Third quarter 2023 results: EPS: ₫524 (down from ₫2,129 in 3Q 2022). Revenue: ₫28.3b (down 10% from 3Q 2022). Net income: ₫1.94b (down 75% from 3Q 2022). Profit margin: 6.8% (down from 25% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₫31,000, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 254% over the past three years. Valuation Update With 7 Day Price Move • Oct 10
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₫32,500, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 201% over the past three years. Upcoming Dividend • Aug 31
Upcoming dividend of ₫2,700 per share at 5.7% yield Eligible shareholders must have bought the stock before 05 September 2023. Payment date: 20 September 2023. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 5.7%. Lower than top quartile of Vietnamese dividend payers (8.6%). In line with average of industry peers (5.4%). New Risk • Jul 26
New minor risk - Revenue size The company makes less than US$5m in revenue. Total revenue: ₫118b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (73% accrual ratio). Market cap is less than US$10m (₫69.2b market cap, or US$2.93m). Minor Risks Paying a dividend despite having no free cash flows. Revenue is less than US$5m (₫118b revenue, or US$5.0m). Reported Earnings • Jul 26
Second quarter 2023 earnings released: EPS: ₫1,117 (vs ₫1,088 in 2Q 2022) Second quarter 2023 results: EPS: ₫1,117 (up from ₫1,088 in 2Q 2022). Revenue: ₫27.8b (down 8.3% from 2Q 2022). Net income: ₫2.07b (up 2.7% from 2Q 2022). Profit margin: 7.4% (up from 6.6% in 2Q 2022). The increase in margin was driven by lower expenses. Reported Earnings • Apr 27
First quarter 2023 earnings released: EPS: ₫1,048 (vs ₫1,322 in 1Q 2022) First quarter 2023 results: EPS: ₫1,048 (down from ₫1,322 in 1Q 2022). Revenue: ₫26.1b (down 24% from 1Q 2022). Net income: ₫1.94b (down 21% from 1Q 2022). Profit margin: 7.4% (up from 7.2% in 1Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 21
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₫47,700, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 9x in the Chemicals industry in Vietnam. Total returns to shareholders of 122% over the past three years. Upcoming Dividend • Mar 14
Upcoming dividend of ₫800 per share at 7.0% yield Eligible shareholders must have bought the stock before 21 March 2023. Payment date: 31 March 2023. Payout ratio is a comfortable 20% but the company is not cash flow positive. Trailing yield: 7.0%. Lower than top quartile of Vietnamese dividend payers (9.0%). In line with average of industry peers (6.7%). Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₫42,900, the stock trades at a trailing P/E ratio of 4.2x. Average trailing P/E is 9x in the Chemicals industry in Vietnam. Total returns to shareholders of 17% over the past year. Reported Earnings • Feb 01
Full year 2022 earnings released: EPS: ₫8,258 (vs ₫6,866 in FY 2021) Full year 2022 results: EPS: ₫8,258 (up from ₫6,866 in FY 2021). Revenue: ₫128.8b (up 8.0% from FY 2021). Net income: ₫15.7b (up 20% from FY 2021). Profit margin: 12% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: ₫4,258 (vs ₫271 in 3Q 2021) Third quarter 2022 results: EPS: ₫4,258 (up from ₫271 in 3Q 2021). Revenue: ₫31.6b (up 58% from 3Q 2021). Net income: ₫7.88b (up ₫7.38b from 3Q 2021). Profit margin: 25% (up from 2.5% in 3Q 2021). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Sep 19
Investor sentiment improved over the past week After last week's 19% share price gain to ₫45,000, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 10x in the Chemicals industry in Vietnam. Total returns to shareholders of 98% over the past three years. Reported Earnings • Jul 23
Second quarter 2022 earnings released: EPS: ₫1,088 (vs ₫1,048 in 2Q 2021) Second quarter 2022 results: EPS: ₫1,088 (up from ₫1,048 in 2Q 2021). Revenue: ₫30.3b (down 13% from 2Q 2021). Net income: ₫2.01b (up 3.7% from 2Q 2021). Profit margin: 6.6% (up from 5.5% in 2Q 2021). The increase in margin was driven by lower expenses. Upcoming Dividend • Jul 12
Upcoming dividend of ₫2,200 per share Eligible shareholders must have bought the stock before 19 July 2022. Payment date: 29 July 2022. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 6.4%. Lower than top quartile of Vietnamese dividend payers (8.0%). Higher than average of industry peers (3.3%). Valuation Update With 7 Day Price Move • May 31
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₫41,500, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 10x in the Chemicals industry in Vietnam. Total returns to shareholders of 74% over the past three years. Valuation Update With 7 Day Price Move • May 09
Investor sentiment improved over the past week After last week's 19% share price gain to ₫56,000, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total returns to shareholders of 151% over the past three years. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: ₫1,322 (vs ₫1,279 in 1Q 2021) First quarter 2022 results: EPS: ₫1,322 (up from ₫1,279 in 1Q 2021). Revenue: ₫34.2b (up 12% from 1Q 2021). Net income: ₫2.45b (up 3.4% from 1Q 2021). Profit margin: 7.2% (down from 7.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improved over the past week After last week's 17% share price gain to ₫48,000, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 13x in the Chemicals industry in Vietnam. Total returns to shareholders of 76% over the past three years. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₫38,500, the stock trades at a trailing P/E ratio of 4.5x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total returns to shareholders of 44% over the past three years. Buying Opportunity • Jan 27
Now 21% undervalued Over the last 90 days, the stock is up 3.2%. The fair value is estimated to be ₫53,273, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.1% per annum over the last 3 years. Earnings per share has grown by 23% per annum over the last 3 years. Reported Earnings • Jan 26
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₫6,866 (up from ₫6,058 in FY 2020). Revenue: ₫119.3b (down 17% from FY 2020). Net income: ₫13.0b (up 13% from FY 2020). Profit margin: 11% (up from 8.0% in FY 2020). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 21% share price gain to ₫44,700, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 15x in the Chemicals industry in Vietnam. Total returns to shareholders of 67% over the past year. Upcoming Dividend • Dec 14
Upcoming dividend of ₫800 per share Eligible shareholders must have bought the stock before 21 December 2021. Payment date: 07 January 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.5%. Within top quartile of Vietnamese dividend payers (6.2%). Higher than average of industry peers (1.9%). Reported Earnings • Oct 23
Third quarter 2021 earnings released: EPS ₫271 (vs ₫703 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₫20.0b (down 40% from 3Q 2020). Net income: ₫501.7m (down 62% from 3Q 2020). Profit margin: 2.5% (down from 3.9% in 3Q 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improved over the past week After last week's 21% share price gain to ₫43,000, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 14x in the Chemicals industry in Vietnam. Total returns to shareholders of 12% over the past three years. Valuation Update With 7 Day Price Move • Aug 20
Investor sentiment improved over the past week After last week's 21% share price gain to ₫38,900, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 15x in the Chemicals industry in Vietnam. Total returns to shareholders of 1.4% over the past three years. Reported Earnings • Jul 24
Second quarter 2021 earnings released: EPS ₫1,048 (vs ₫892 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₫35.0b (up 6.3% from 2Q 2020). Net income: ₫1.94b (up 18% from 2Q 2020). Profit margin: 5.5% (up from 5.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 25
Inaugural dividend of ₫2,200 per share Eligible shareholders must have bought the stock before 01 June 2021. Payment date: 11 June 2021. The company last paid an ordinary dividend in October 2011. The average dividend yield among industry peers is 4.5%. Is New 90 Day High Low • Mar 01
New 90-day high: ₫33,800 The company is up 20% from its price of ₫28,100 on 01 December 2020. The Vietnamese market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period. Reported Earnings • Jan 19
Full year 2020 earnings released: EPS ₫6,058 The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: ₫143.9b (flat on FY 2019). Net income: ₫11.5b (up 80% from FY 2019). Profit margin: 8.0% (up from 4.4% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jan 08
Upcoming Dividend of ₫800 Per Share Will be paid on the 29th of January to those who are registered shareholders by the 15th of January. The company last paid an ordinary dividend in October 2011. The average dividend yield among industry peers is 5.8%. Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₫27,500, the stock is trading at a trailing P/E ratio of 7.6x, down from the previous P/E ratio of 9x. This compares to an average P/E of 12x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 5.7%. Valuation Update With 7 Day Price Move • Nov 28
Market bids up stock over the past week After last week's 20% share price gain to ₫23,600, the stock is trading at a trailing P/E ratio of 6.5x, up from the previous P/E ratio of 5.4x. This compares to an average P/E of 13x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 12%. Valuation Update With 7 Day Price Move • Oct 29
Market pulls back on stock over the past week After last week's 19% share price decline to ₫21,900, the stock is trading at a trailing P/E ratio of 6.1x, down from the previous P/E ratio of 7.5x. This compares to an average P/E of 12x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 18%. Reported Earnings • Oct 23
Third quarter earnings released Over the last 12 months the company has reported total profits of ₫6.70b, down 2.7% from the prior year. Total revenue was ₫142.2b over the last 12 months, largely unchanged from the prior year. 
